Variable levels of bcl-2, bcl-x and bax mRNA in bladder cancer progression.

  • Authors:
    • P Gazzaniga
    • A Gradilone
    • I Silvestri
    • O Gandini
    • L Giuliani
    • A Vincenzoni
    • M Gallucci
    • L Frati
    • A M Agliano
  • View Affiliations

  • Published online on: Wednesday, July 1, 1998
  • Pages: 901-905 DOI: 10.3892/or.5.4.901

Abstract

We investigated the expression of the anti-apoptotic genes bcl-2 and bcl-X and the pro-apoptotic gene bax in bladder tumors and normal samples from urinary bladder, using RT-PCR analysis. Bcl-2 mRNA was not detected in any of the normal samples, while it was found expressed in 66% of the low stage tumors and in 100% of the high stage tumors. Bax expression had an inverse progress, being present in 62% of the normal tissues examined, in 16% of the low stage tumors and in 14% of the high stage. Bcl-X gene expression was quite variable among all samples (37% in normal tissues, 50% in the low stage tumors and 14% in the high stage). bcl-X mRNA was only found in the isoform bcl-XL, with anti-apoptotic functions, whereas no sample expressed the isoform bcl-XS, which is known to suppress bcl-2 functions. Most samples expressing bcl-2 did not express bcl-X, and vice versa. These results, besides confirming the potential role of these genes in the pathogenesis of low stage bladder cancer strengthen the hypothesis concerning their possible interaction in the progression of disease.

Related Articles

Journal Cover

July 1998
Volume 5 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

2015 Impact Factor: 2.486
Ranked #31/211 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Gazzaniga, P., Gradilone, A., Silvestri, I., Gandini, O., Giuliani, L., Vincenzoni, A. ... Agliano, A. (1998). Variable levels of bcl-2, bcl-x and bax mRNA in bladder cancer progression.. Oncology Reports, 5, 901-905. http://dx.doi.org/10.3892/or.5.4.901
MLA
Gazzaniga, P., Gradilone, A., Silvestri, I., Gandini, O., Giuliani, L., Vincenzoni, A., Gallucci, M., Frati, L., Agliano, A."Variable levels of bcl-2, bcl-x and bax mRNA in bladder cancer progression.". Oncology Reports 5.4 (1998): 901-905.
Chicago
Gazzaniga, P., Gradilone, A., Silvestri, I., Gandini, O., Giuliani, L., Vincenzoni, A., Gallucci, M., Frati, L., Agliano, A."Variable levels of bcl-2, bcl-x and bax mRNA in bladder cancer progression.". Oncology Reports 5, no. 4 (1998): 901-905. http://dx.doi.org/10.3892/or.5.4.901